Statistics for KNIGHT THERAPEUTICS INC (id:13521 GUD)
Valuation metrics
Market cap
537.28M
Enterprise value
426.20M
Trailing P/E (ttm)
-33.12
Forward P/E
59.22
PEG ratio
59.22
Price/Sales (ttm)
1.54
Price/Book (mrq)
3.00
Enterprise Value/Revenue
1.22
Enterprise Value/EBITDA
7.43
Overview
Shares outstanding
100.80M
Float
86.03M
Shares short
3.24M
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
65.22K
Average volume (90 days)
Price summary
52-Week low
5.08
52-Week high
6.23
52-Week change
3.00%
Beta
3.00
50-Day moving average
5.50
200-Day moving average
5.65
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-8.81%
Operating margin
3.47%
Operational effectiveness
Return on assets
3.00%
Return on equity
-3.87%
Income statement
Revenue (ttm)
3.42
Revenue per share (ttm)
3.42
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
152.65M
EBITDA
73.49M
Net income to common (ttm)
-30,729,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
-99.10%
Balance sheet
Total cash (mrq)
172.32M
Total cash per share (mrq)
1.71
Total debt (mrq)
58.22M
Total Debt/Equity (mrq)
7.52
Current ratio (mrq)
336.50%
Book value per share (mrq)
7.66
Cash flow
Cash flow statement
52.75M
Levered free cash flow (LFCF)
45.96M